Condition: Chronic Lymphocytic Leukemia · CLL · Progressive Chronic Lymphocytic Leukemia · Sponsor: University Hospital, Clermont-Ferrand
The purpose of this study is to collect medical informations and samples from refractory and/or relapsed chronic lymphocytic leukemia during or after venetoclax treatment, in order to evaluate the frequency of resistance mechanisms.
This description comes directly from the study's public registry record.
Lise Laclautre · 334.73.754.963 · promo_interne_drci@chu-clermontferrand.fr
Always discuss trial participation with your own doctor first.
| CHU d'Amiens | Amiens, France | Not Yet Recruiting |
| CHU de Besançon | Besançon, France | Not Yet Recruiting |
| Hopital AVICENNE | Bobigny, France | Not Yet Recruiting |
| CHU clermont-ferrand | Clermont-Ferrand, France | Not Yet Recruiting |
| CHU de Clermont Ferrand | Clermont-Ferrand, France | Not Yet Recruiting |
| CHU Grenoble | Grenoble, France | Not Yet Recruiting |
| CHRU de Lille | Lille, France | Not Yet Recruiting |
| Centre LEON BERARD | Lyon, France | Not Yet Recruiting |
| CHU de Montpellier | Montpellier, France | Not Yet Recruiting |
| CHU Nancy | Nancy, France | Not Yet Recruiting |
| Hopital Pitié Salpetrière | Paris, France | Not Yet Recruiting |
| Hopital Haut LEVEQUE | Pessac, France | Not Yet Recruiting |
+ 2 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05246345